Lipids in association with serum magnesium in diabetes mellitus patients

Acta Angiologica

Volumn 12, Issue 4, 2006, Pages 149-154

  Nasri, Hamid ^a  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes mellitus; Lipoprotein (a); Serum lipids; Serum magnesium

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BIGUANIDE; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; ISOPHANE INSULIN; MAGNESIUM; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DIET SUPPLEMENTATION; FEMALE; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAGNESIUM BLOOD LEVEL; MAGNESIUM DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OSTEOLYSIS; RETINOPATHY;

EID: 33947307211     PISSN: 1234950X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Levine C, Colburn JW (1984) Magnesium, the mimic/antagonist of calcium. N Engl J Med, 19: 1253-1254.
2. Gums JG (1987) Clinical significance of magnesium: a review. Drug Intell Clin Pharm, 21: 240-246.
3. Maltezos E, Papazoglou D, Exiara T, Kambouromiti G, Antonoglou C (2004) Serum magnesium levels in non-diabetic offspring of patients with type 2 diabetes mellitus. Diabetes Nutr Metab, 17: 12-16.
4. McNair P, Christiansen C, Madshad S et al (1978) Hypomagnesemia, a risk factor in diabetic retinopathy. Diabetes, 27: 961-965.
5. Mather HM, Nisbet JA, Bruton GH et al (1979) Hypomagnesemia in diabetes. Clin Chem Acta, 95: 235-242.
6. Fuji S, Tekemura T, Wada M, Akai T, Okuta KM (1982) Magnesium levels in plasma, erythrocyte and urine in patients with diabetes mellitus. Horn Metab Res, 14: 161-162.
7. Johansson G, Danielsson BG, Ljunghall S, Wibell L (1982) Evidence for a disturbed magnesium metabolism in diabetes mellitus. Magnesium, 3: 178-180.
8. Ewald U, Gebre-Medhin M, Tuvemo T (1983) Hypomagnesemia in diabetic children. Acta Padediatr Scand, 72: 367-371.
9. Tuvemo T, Ewald U, Kobbah M, Proos LA (1997) Serum magnesium and protein concentrations during the first years of insulin-dependent diabetes in children. Acta Paediatr, 418: 7-10.
10. Gebre-Medhin M, Kylberg E, Ewald U, Tuvemo T (1985) Dietary intake, trace elements and serum protein status in young diabetics. Acta Paediatr Scand, 74 (suppl): 38-43.
11. Paolisso G, Barbagallo M (1997) Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens, 10: 346-355.
12. Paolisso G, Ravussin E (1995) Intracellular magnesium and insulin resistance: results in Pima Indians and Caucasians. J Clin Endocrinol Metab, 80: 1382-1385.
13. Lefebvre PJ, Paolisso G, Scheen AJ (1994) Magnesium and glucose metabolism. Therapie, 49: 1-7.
14. Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R (1993) Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension, 21: 1024-1029.
15. Paolisso G, Scheen A, D'Onofrio F, Lefebvre P (1990) Magnesium and glucose homeostasis. Diabetologia, 33: 511-514.
16. Resnick LM (1992) Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders. Am J Med, 93: 11S-20S
17. Schnack C, Bauer I, Pregant P, Hopmeier P, Schernthaner G (1992) Hypomagnesemia in type 2 (non-insulin-dependent) diabetes mellitus is not corrected by improvement of long-term metabolic control. Diabetologia, 35: 77-79.
18. Isbir T, Tamer L, Taylor A, Isbir M (1994) Zinc, cooper and magnesium status in insulin-dependent diabetes. Diabetes Res, 26: 41-45.
19. Fox C, Ramsoomair D, Carter C (2001) Magnesium: it's proven and potential clinical significance. South Med J, 94: 1195-1201.
20. Altura BM, Altura BT (1981) Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases. Fed Proc, 40: 2672-2679.
21. Gerrad JM, Stuard MJ, Rao GHR et al (1980) Alteration in balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med, 95: 950-958.
22. Nadler JL, Rude RK (1995) Disorders of magnesium metabolism. Endocrinol Metab Clin North Am, 24: 623-641.
23. Nadler JL, Malayan S, Luong H et al (1992) Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care, 15: 835-841.
24. Altura BM, Altura BT, Gebrewald A (1984) Magnesium deficiency and hypertension: correlation between magnesium-deficient diets and microcirculatory changes in situ. Science 1984; 223: 1315-1317.
25. Altura BM, Altura BT (1985) New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system: clinical aspects. Magnesium, 4: 226-244.
26. Hagg E, Carlberg BC, HillronVS, Villumsen J (1999) Magnesium therapy in type I diabetes. A double blind study concerning the effects on kidney function and serum lipid levels. Magnes Res, 12: 123-130.
27. Robles NR, Escola JM, Albarran L, Espada R, Cruz A (1998) Correlation of serum magnesium and serum lipid levels in hemodialysis patients. Dial Transplant, 27: 644-648.
28. Nasri H, Baradaran A (2004) Correlation of serum magnesium with dyslipidemia in maintenance hemodialysis patients. Acta Medica, 47: 4263-4265.
29. Corica F, Allegra A, Di Benedeto A et al (1994) Effects of oral magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. Magnes Res, 7: 43-47.
30. Lal J, Vasudev K, Kela AK, Jain SK (2003) Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus. J Assoc Physicians India, 51: 37-42.
31. Friedewald WT, Levy R, Fredrickson DS (1972) Estimation of the concentration of Low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem, 18: 799-502.
32. Cockcroft DW, Gault MH (1976) Prediction of creatinin clearance from serum creatinine. Nephron 16: 31-41.
33. American Diabetic Association (1992) Magnesium supplementation in the treatment of diabetes a consensus statement. Diabetes Care, 15: 10651067.
34. Paolisso G, Seheen A, D'Onofrio F, Lefebvre P (1990) Magnesium and glucose homeostasis. Diabetologia, 33: 511-514.
35. Mooradian AD, Morley JE (1987) Micronutrient status in diabetes mellitus. Am J Clin Nutr, 45: 877-895.
36. Cadell JL (1991-1992) Magnesium in perinatal care and infant health. Magnes Trace Elem, 10: 229-250.
37. Wester PO (1987) Magnesium. Am J Clin Nutr, 45 (suppl): 1305-1312.
38. Vanroelen WF, Van Gaal LF, Van Rooy PE, De Leeuw IH (1985) Serum and erythrocyte magnesium levels in type I & type II diabetics. Acta Diabetol Lat, 22: 185-190.
39. Nadler JL, Malayans S, Loung H, Shaw S, Nataranjan RD, Rude RK (1992) Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care, 15: 835-841.
40. Mather HM, Levin GE (1979) Magnesium status in diabetes. Lancet, 1: 924.
41. Smith RG, Heise CC, King JC, Costa FM, Kitzmiller JL (1988) Serum and urinary magnesium, calcium and copper levels in insulin dependent diabetic women. J Trace Elem Electrolytes Health Dis, 2: 239-243.
42. Streter DHP, Gerstein MM, Marmor BM, Doisy RJ (1965) Reduced glucose tolerance in elderly human subjects. Diabetes, 14: 579-583.
43. American Diabetes Association (1992) Magnesium supplementation in the treatment of diabetes. Diabetes Care, 14: 1065-1067.
44. Schroeder HA, Balassa JJ, Tipton IA (1962) Abnormal trace metals in man. J Chron Dis, 15: 941-964.
45. Seelig MS, Heggtyeit A (1974) Magnesium interrelationship in ischemic heart disease. Am J Clin Nutr, 27: 59-79.
46. Stutzman FL, Amatuzio DS (1953) Blood serum magnesium in portal cirrhosis and diabetes mellitus. J Lab Clin Ned, 41: 215-219.
47. Seeling MS, Heggtveit HA (1974) Magnesium interrelationships in ischemic heart disease: a review. Am J Clin Nutr, 27: 59-79.
48. Ceriello A, Guiglano D, Dello Russo P, Passariello N (1980) Hypomagnesemia in relation to diabetic retinopathy. Diabetes Care, 5: 558-559.
49. Rude K, Oldham SB, Sharp CF et al (1978) Parathyroid hormone secretion in magnesium deficiency. J Clin Endocrinol Metab, 47: 800-806.
50. Rude K, Adams JS, Ryzen E et al (1985) Parathyroid hormone secretion in magnesium deficiency. J Clin Endocrinol Metab, 61: 933-940.
51. Baydas B, Karagos S, Meral I (2002) Effects of oral zinc and magnesium supplementation on serum thyroid hormone and lipid levels in experimentally induced diabetic rats. Biol Trace Elem Res, 88: 247-253.
52. Boemi M, Sirolla C, Fumelli P, James RW (1999) Renal disease as a determinant of increased lipoprotein concentrations in diabetic patients. Diabetes Care, 12: 2033-2036.
53. Heesen BJ, Wolfenbuttel BH, Leurs PB et al (1993) Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin dependent diabetes. Eur J Clin Invest, 23: 580-584.
54. Purvis JR, Movahed A (1992) Magnesium disorders and cardiovascular diseases. Clin Cardiol, 15: 556-568.